Cargando…
Baseline blood immunological profiling differentiates between Her2–breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response
PURPOSE: Breast cancer patients’ response to treatment is highly dependent on the primary tumor molecular features, with triple-negative breast tumors having the worst prognosis of all subtypes. According to the molecular features, tumors stimulate the microenvironment to induce distinct immune resp...
Autores principales: | Tudoran, Oana, Virtic, Oana, Balacescu, Loredana, Lisencu, Carmen, Fetica, Bogdan, Gherman, Claudia, Balacescu, Ovidiu, Berindan-Neagoe, Ioana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655955/ https://www.ncbi.nlm.nih.gov/pubmed/26604799 http://dx.doi.org/10.2147/OTT.S91720 |
Ejemplares similares
-
Blood Genome-Wide Transcriptional Profiles of HER2 Negative Breast Cancers Patients
por: Balacescu, Ovidiu, et al.
Publicado: (2016) -
Differential Peripheral Blood Gene Expression Profile Based on Her2 Expression on Primary Tumors of Breast Cancer Patients
por: Tudoran, Oana, et al.
Publicado: (2014) -
Breast cancer stem-like cells: clinical implications and therapeutic strategies
por: TUDORAN, OANA MIHAELA, et al.
Publicado: (2016) -
Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells
por: Tudoran, Oana, et al.
Publicado: (2012) -
Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients
por: Baldasici, Oana, et al.
Publicado: (2022)